

No data available
No data available
No data available
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Revenue | 163.68 | 128.11 | 82.98 | 52.31 |
| Total Expenses | 150.53 | 119.52 | 79.53 | 50.80 |
| Profit Before Tax | 13.15 | 8.59 | 3.44 | 1.51 |
| Profit After Tax | 9.81 | 6.31 | 2.51 | 1.39 |
| Operating Profit After Depreciation | 13.69 | 9.11 | 3.92 | 1.97 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Fixed Assets | 5.92 | 2.69 | 3.97 | 2.98 |
| Total Non Current Assets | 9.08 | 9.80 | 8.28 | 5.70 |
| Total Current Assets | 54.66 | 11.95 | 6.43 | 6.69 |
| Total Assets | 63.74 | 21.75 | 14.71 | 12.39 |
| Total Shareholder's Fund | 51.50 | 9.43 | 3.27 | 0.77 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 |
|---|---|---|
| Net Cash From Operating Activities | -5.07 | 7.04 |
| Net Cash Used In Investing Activities | -0.31 | -2.61 |
| Net Cash Used In Financing Activities | 33.56 | -2.57 |
No data available
No data available
₹0.7/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
No data available
On 5 May 2026
30 Apr 2026, 11:12 am
On 13 May 2026
22 Apr 2026, 10:05 am
On 13 May 2026
20 Apr 2026, 12:40 pm
On 18 April 2026
16 Apr 2026, 09:53 am
On 19 February 2026
14 Feb 2026, 09:50 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.